ClearanceBrief
Recall Z-1351-2023 ยท FIP Subsystem, Water Purification

Outset Medical, Inc.

Outset Tablo Model Numbers (REF): PN-0006000 PN-0007001 Tablo is a next generation, self-contained hemodialysis system (Hemodialysis System or System), intended for acute, home and chronic dialysis therapy with or without ultrafiltration, in an acute or chronic care facility.

DateApr 7, 2023 (initiated Jan 24, 2023)
StatusOpen, Classified
ReasonAn observed trend of high conductivity dialysate alarms in a hemodialysis system as a result of introducing a software tool into the manufacturing process.
Root causeProcess control
ActionOn 01/24/2023, the firm communicated an "MEDICAL DEVICE FIELD ACTION" Letter via FedEx Standard Overnight to customers informing them that Outset Medical has identified that Tablo Hemodialysis Systems manufactured between May 2021 and February 2022 require recalibration of the conductivity sensor, due to the dialysate conductivity sensor giving potentially false trigger alarms such as Alarm_Dialysate_Conductivity_High or Dialysate Conductivity Error. In addition, in devices where recalibration is needed and isolated only to treatments where the prescribed sodium is less than or equal to 133mE
Quantity374 systems
DistributionU.S. Nationwide distribution including in the states of AK, AL, AR, CA, CO, FL, GA, HI, IA, ID, IL, IN, MI, MS, MO, MT, NE, NV, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX, UT, VT, VA, and WI. O.U.S.: Not provided.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K190793Tablo Hemodialysis System, Tablo Cartridge
Outset Medical, Inc., Dec 12, 2019
K211370Tablo Hemodialysis System
Outset Medical, Inc., Jul 29, 2022